Related Experiment Video
Updated: Jun 1, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
New agents in follicular lymphoma
1Georgetown University Hospital, Lombardi Comprehensive Cancer Center, 3800 Reservoir Rd NW, Washington, DC 20007, United States. bdc4@georgetown.edu
Best Practice & Research. Clinical Haematology
|June 11, 2011
Summary
Follicular lymphoma treatment has advanced with chemoimmunotherapy, but the disease remains incurable. New targeted agents and combinations are being developed to improve patient outcomes and overcome relapses.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma.
- FL is generally responsive to chemotherapy but historically incurable with high relapse rates.
Purpose of the Study:
- To review current and emerging therapeutic strategies for follicular lymphoma.
- To highlight the role of novel agents and combination therapies in improving patient outcomes.
Main Methods:
- Review of current literature on follicular lymphoma treatment.
- Discussion of novel targeted agents and their mechanisms of action.
- Emphasis on the rationale for developing combination therapies.
Main Results:
- Monoclonal antibodies like rituximab have improved survival in FL.
- Numerous novel agents targeting cellular pathways (e.g., Syk, BTK, mTOR, PI3K) and the tumor microenvironment (e.g., lenalidomide) are under investigation.
- Bendamustine and bortezomib are among chemotherapy agents being re-evaluated in combination strategies.
Conclusions:
- Follicular lymphoma remains a challenging disease requiring innovative treatment approaches.
- Development of novel drug combinations based on scientific rationale and correlative studies is crucial.
- Further research is needed to overcome treatment resistance and achieve cures for FL patients.
More Related Videos
Related Concept Videos
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:15Secondary Lymphoid Organs
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
01:18Lymphoid Cells and Tissues
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...